| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| dcc-2036 | tyrosine-protein kinase abl1 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Myeloid Leukemia Chronic[MeSHID:D015464] Malignant neoplasm of breast[MeSHID:D001943] |
0.58 | phase 1/2 | unknown |
| dcc-2036 | angiopoietin 1 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Myeloid Leukemia Chronic[MeSHID:D015464] Malignant neoplasm of breast[MeSHID:D001943] |
0.71 | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||